Wearable Devices (Clinical Trials) Market Intelligence

Report Coverage

  • Market Trends
  • Technology & Innovation Trends
  • Global Supplier List and Capabilities

Market Size

Global Market Size

$ 8.1 Bn


18.9 Percent

Market Size North America

$ 2.43 Bn

Market Size Asia Pacific

$ 2.51 Bn

Table of contents

  1. Wearable Devices Executive Summary
  2. Category Definition
  3. Executive Summary
  1. Wearable Devices Market Analysis
  2. Market Overview
  3. Challenges in Using Wearables
  4. Market Trends
  1. Wearable Devices Supplier Analysis
  2. Supplier List (Worksheet Attached)
  3. Supplier Profiles
  4. Collaborations that Enhance Wearable Tech
  1. Wearable devices Sourcing Practices
  2. Engagement and Pricing Models
  1. Wearable Devices Competative Intelligence
  2. Supplier and Pharma Collaboration for Digital Technology
  3. Service Providers Collaboration to Enhance
  4. Digital Tech Offering

Want a more detailed personalised report?

Global Market Outlook on Wearable Devices

  • The Center for Technology and Aging, has stated that $200 billion can be saved for the next 25 years by the US healthcare system by the adoption of remote patient monitoring technologies. However, the implementation of these technologies like wearable medical devices in the clinical trials is at infancy
  • Mobile Health Technology, though in early stages, has attracted the pharma industry to utilize them in clinical trials for better trial outcomes and also to shorten the trial timeline. In a survey, which included respondents from sponsors, consultants, CROs, academia, and labs said that the ~78 percent of them have been using mHealth in clinical trials for more than a year (Sources: Applied Clinical Trials, SCORR Marketing)

  • In spite of massive benefits of implementing the wearables in clinical trials, two-third of the industry has not seen the RoI because they have not used wearables in long term and drug development timeline are on average 10 years now


Challenges In Using Wearables

Accuracy, standardization and analysis of wearable-generated data

The data associated with wearables are voluminous. It has always been a challenge for the CROs and sponsors on how to handle wearable-generated data. It is important that the data received should be standardized and ready to be integrated in to the clinical trial platforms and data collected in an uncontrolled research environment should be converted into meaningful outcomes by laying structured guidance/procedures to be clinical trial-compliant

Data Security/Privacy Concerns and misuse

Cisco predicts that there would be 600 million wearables data online, globally by 2020. This demands the regulators and device manufacturers to pack in data security protocols into the wearable devices to prevent the patients from encountering cybersecurity attacks. As these data are stored in clouds they could be retrieved without the knowledge of the user. Activity trackers, are however considered as inoffensive, but the user maybe unaware of how those long-term collected data could be misused by a third-party. E.g., insurance providers, who can either cancel the policy or quote high health insurance price

Reluctance in adoption of wearable devices

Though the use of mobile phones and apps might advance, there will be only less than ten percent of clinical trials that will use wearables by 2017, according to Gartner. Wider adoption of wearables could be a challenge and barriers to recommendation to the patients are:

1) Unavailability of smart phones with all patients

2) Inconsistent device use leading to incomplete data

3) Integration of the wearable data with the existing e-health management systems

4) Reluctance showed by the physicians to adopt this technology as the data collected are large and data analysis is a challenge to them as they don't have time or does not have the skill set

Lack of guidance from FDA to use wearable devices in CTs

With the upsurge in use of wearables for health monitoring and social media for patient recruitment in clinical trials Association of Clinical Research (ACRO) has sked the FDA to update the guidelines for the wearables and softwares, so that the sponsor and CRO can be encouraged to use it.

  • Issue a public statement for the use of new technologies in a clinical trial conduct
  • To analyze the barriers and benefits with the help of the industry (pharma, CRO, patients, and technology providers)
  • Provide clear guidance documents for use of tech-driven solutions in terms of data security and monitoring parameters/requirements

Trends in Wearables 

  • Healthcare providers can collect data from patients, as well as use wearable technology to keep doctors connected to co-workers and data without the hassle of a pager or phone system
  • The boom in wearable technology and wearable devices market size has been mainly fueled by fitness, such as wearable gadgets that monitor heart rate or track your exercise. These gadgets have been successful because they are helpful to the user and easy to integrate into everyday life
  • The wearable devices market growth will be fueled almost exclusively by smartwatches and wrist-worn fitness trackers. Compared to other modes of wearables, wristwear shipment is forecast to be 126.1 million by 2019


Precision Medicine

  • Data from wearables can be valuable in personalized medicine when combined with the genetic data, aiding to identify right patients for the right treatment at the right time 

  • Precision Medicine Initiative: The Precision Medicine Initiative launched by President Obama valued $215 million (for the fiscal year 2016), out of which, $130 million is allocated to create the database (participant group or cohort) and $5 million to facilitate clinical data inter-operability

Phase-I Trials

The crucial of all the phases in clinical development is Phase-I, as it tests the drug safety on healthy volunteers. Incorporating wearable devices can:

  • Continuously monitor the patients and supply real-time data
  • Eradicate human errors associated with data capture
  • Detect medication adherence and response to the treatment off-site through remote monitoring

IoT System

  • The technologies with the perceived most disruptive potential in the next five years are artificial intelligence and remote monitoring. Wearables, IoT, virtual reality, 3D printing, and blockchain are next in the ranking, leaving 5G as the least disruptive
  • Most mobile health publishers are rather new to the market, these established and successful stakeholders can serve as best-in-class or role models and pave the way for the new breed of digital intruders
  • The popularity of health insurers as a distribution channel has been slowly increasing over the years and has even overtaken “app stores” as the best distribution channel

Technology Innovation in Sensors

  • These are digital devices, which can be worn on the body, ingestible pill-like sensors, patches, tattoos, ring, spectacles, and clothing that captures continuous patient biometric data
  • SPHERE (Sensor Platform for healthcare in a residential environment), an Interdisciplinary Research Collaboration (IRC) with the vision of establishing a common platform of non-medical/environmental sensors to impact a variety of healthcare needs
  • Wireless BSN technology: A mobile physiological monitoring system, which is able to continuously monitor the patient’s heartbeat, blood pressure, and other critical parameters in the hospital. The system is able to carry out long-term monitoring on patient’s condition

Market Trends

Wearables will become an essential part of everyday life, like smartphones and mobile apps, as technology becomes more affordable and reachable, paving a path for remote patient monitoring. 

Wearable IoT in Healthcare

Wearable devices and apps are powerful tools to save both cost and time at hospitals by providing physicians with an easy track of a patient's condition, thereby allowing them to develop critical insights and provide an advanced diagnosis. Certain wearable devices are capable of measuring ECG samples on a periodic basis, aiding healthcare professionals to monitor the patients virtually and remotely.

GPS Technology in Smartwatches

Technologically advanced wearable devices and smartphones come with gyroscopes, compasses, accelerometers, and motion trackers. This combined data will enable wearable devices to calculate pulse, speed, distance traveled, and total calories burnt. This will further improve the accuracy of measurements and values obtained from wearable devices. 

Data collection and Real-World Evidence (RWE) 

Wearable devices will enable advanced data collection and the creation of more diverse datasets. This information can be aggregated, linked, and processed by digital marketers to understand key aspects, such as buying habits, location of the target audience, clinical trial-related data, and can be processed to produce key conclusions in the form of RWE. 

Trends In Wearables

Healthcare providers can collect data from patients, as well as use wearable technology to keep doctors connected to co-workers and data without the hassle of a pager or phone system.

The boom in wearable technology has been mainly fueled by fitness, such as wearable gadgets’ that monitor your heart rate or track your exercise. These gadgets have been successful because they are helpful to the user and easy to integrate into everyday life.

The market’s growth will be fuelled almost exclusively by activity monitors and wrist-worn fitness trackers. The market is observing the evolution and growing acceptance of wearable injectors emphasizing patient-centric, convenient, cost-effective, and user-friendly wearable drug delivery solutions in-home care settings.

Innovation Framework

Wearables are used in a widespread way to collect physiological touchpoints, this in turn can be used to monitor a patient's health remotely. 

Data Collection 

  • Virtual trials are on the rise, and FDA approved clinical-grade wearables are making it easier by collecting precise physiological measures 

  • A medical device company is collecting data of patients at the risk of Alzheimer's and related disorders, by capturing gait and actigraphy measures. The sensor is present in the insole worn in normal footwear and a wrist-worn device for continuous monitoring. The wearable will also assess the difference between the data collected by the device and the standard function test data 

Patient Experience 

  • Pharma is becoming more patient-centric and pharma companies are using mobile technology to make clinical development relevant to patient’s experience living with chronic disease

  • A top pharma company is in collaboration with a few universities, like the University of Rochester, Boston University, and the University of San Diego, and has a wearable motion tracker for a dermatological disease. They have included various measures like tracking of scratching during sleep, frequency, incidence, and duration to give real-world data of the patients.

Wearable Devices (Clinical Trials) Market Frequently Asked Questions

  1. What is the expected growth for the wearable devices market?
  2. The wearable devices market growth is expected to continue at a CAGR of 29-30 percent through 2020.


  1. Who are the key market suppliers for wearable devices?
  2. The key suppliers for the wearable devices market are ActiGraph, Vital Connect, Validic, BioSensics, ERT, BioClinica, Alive Technologies, LifeWatch, and Medtronic.


  1. What are the market drivers for wearable devices?
  2. Some of the factors that are driving the wearable devices market are –
    - addressing patient recruitment challenges
    - remote monitoring of patients
    - patient adherence
    - real-time data capture to amend the clinical trial design, precision medicine


  1. Are there any market constraints for the wearable devices market?
  2. Some of the market constraints of the wearable devices market are mentioned as follows.
    - Accuracy, standardization, and analysis of wearable-generated data
    - Concerns regarding data security, privacy, and misuse
    - Unwillingness to adopt wearable devices
    - Lack of guidance from the FDA


  1. What are the trends in the wearables market?
  2. The following are the trends in the wearables market.
    - The use of wearable technology, enabled doctors and healthcare providers to stay connected to their co-workers without depending on a pager or phone system.
    - Wearable devices gained more popularity when they started coming with features that monitor heart rate or track the user’s exercise and sleep patterns.
    - The major contributor to the wearables market growth is the increase in the use of smartwatches and fitness trackers worn over the wrist. Wristwear shipment is more popular than other modes of wearables.


  1. Which is the fastest-growing market region for wearable devices?
  2. As per the wearable devices market research by Beroe, the Asia Pacific region owns about 31 percent of the total market share and is the fastest-growing market. On the other hand, a major part of the market, i.e., 60 percent of the market share is with North America and Europe combined.


  1. Are there any significant collaborations in the wearables market space?
  2. In wearable devices market news, the collaboration of Paraxel with Sanofi to research the role of wearables in clinical trials is a significant one. In their research projects, sensor-enabled devices have increasingly been features and their accuracy and efficacy have been studied.


  1. What are the technological innovations brought forth in sensors and healthcare needs?
  2. The technological innovations in the field of sensors are as follows.
    - Digital devices, such as ingestible pill-like sensors, patches, tattoos, rings, spectacles and clothing that capture continuous patient biometric data
    - Wireless BSN technology, a mobile physiological monitoring system, which can continuously monitor critical parameters of a patient in the hospital including heartbeat and blood pressure
    - SPHERE (Sensor Platform for HEalthcare in a Residential Environment), an Interdisciplinary Research Collaboration, works with the objective of establishing a common platform of non-medical or environmental sensors.


  1. What is the pricing model for the wearable market?
  2. The most preferred pricing model is volume-based pricing, but an alternative model, i.e. FTE or Full-Time Equivalent is also present.

Complimentary 12-month access to Beroe LiVE

Any more questions?

Get in touch with us quickly and easily.


COVID-19: Assess impact on your suppliers and ensure business continuity with Beroe’s WIRE
(World Instant Risk Exposure)